Sublingual immunotherapy in daily medical practice: Effectiveness of different treatment schedules IPD meta-analysis

Current Medical Research and Opinion

Volumn 26, Issue 4, 2010, Pages 925-932

  Sieber, Jochen ^a   Köberlein, Juliane ^b   Mösges, Ralph ^b  

^a Stallergnes GmbH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Allergic rhinitis; Effectiveness; Meta analysis; Sublingual immunotherapy; Ultra rush titration

Indexed keywords

POLLEN ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POACEAE; POLLEN; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREES;

EID: 77949528232     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007991003659483     Document Type: Article

References (32)

1. Bousquet J, van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl 5):S147-334
2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63 (Suppl 86):8-160
3. Bousquet J, Lockey R, Malling HJ, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998; 81:401-405
4. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12
5. Penagos M, Compalati E, Tarantini F, et al. Efficacy of sublingual immunother-apy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141-148
6. Canonica GW, Bousquet J, Casale TB, et al. Sub-lingual immunotherapy. World Allergy Organization Position Paper 2009. Allergy 2009;64 (Suppl 91):1-59
7. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120:1338-1345
8. Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immu-notherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64:1394-1401
9. Frati F, Scurati S, Puccinelli P, et al. Development of an allergen extract for sublingual immunotherapy-evaluation of Staloral. Expert Opin Biol Ther 2009;9:1207-1215
10. Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005; 35:565-571
11. Feliziani V, Lattuada G, Parmiani S, et al. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:224-230
12. Vervloet D, Birnbaum J, Laurent P, et al. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhino-conjunctivitis. A double-blind, placebo-controlled study. Int Arch Allergy Immunol 2007;142:239-246
13. Gammeri E, Arena A, D'Anneo R, et al. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma. Allergol Immunopathol (Madr) 2005;33:142-144
14. Tripodi S, Di Rienzo Businco A, Benincori N, et al. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Int Arch Allergy Immunol 2006;139:149-152
15. Seidenberg J, Pajno GB, Bauer CP, et al. Safety and tolerability of seasonal ultra-rush high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents. J Investig Allergol Clin Immunol 2009;19:125-131
16. Ariano R, Incorvaia C, La Grutta S, et al. Safety of sublingual immunotherapy started during the pollen season. Curr Med Res Opin 2009;25:103-107
17. de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy 2009;64:963-964
18. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immu-notherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493-498
19. Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sub-lingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123:160-166 e3
20. Golden DB, Valentine MD, Kagey-Sobotka A, et al. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med 1980;92:620-624
21. Vent J, Lehmacher W. The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhi-noconjunctivitis when both groups receive active rescue treatment. Curr Opin Allergy Clin Immunol 2009;9:222-227
22. Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004;59: 45-53
23. Di Rienzo V, Pagani A, Parmiani S, et al. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-1113
24. Di Rienzo V, Minelli M, Musarra A, et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005;35:560-564
25. Drachenberg KJ, Urban E, Proll S, et al. Sublingual specific immunotherapy for adults and children: a post-marketing surveillance study. Allergol Immunopathol (Madr) 2004;32:76-81
26. Fiocchi A, Pajno G, La Grutta S, et al. Safety of sublingual-swallow immu-notherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol 2005;95:254-258
27. Rolinck-Werninghaus C, Wolf H, Liebke C, et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhino-conjunctivitis to grass pollen. Allergy 2004;59:1285-1293
28. Bodtger U, Poulsen LK, Malling HJ. Retrospective assessment of seasonal allergic symptoms: over-rating but useful. Clin Exp Allergy 2003;33:496-500
29. Flay BR. Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Prev Med 1986;15:451-474
30. Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. Pharmacoeconomics 1999;15:423-434
31. Sutton A, Abrams K, Jones D, et al. Methods for meta-analysis in medical research. Chichester: Wiley & Sons, 2000
32. Friedenreich CM. Methods for pooled analyses of epidemiologic studies. Epidemiology 1993;4:295-302